What to do for a blood glucose level of hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Blood Glucose Level of 500 mg/dL

A blood glucose level of 500 mg/dL requires immediate medical attention and treatment with insulin therapy to prevent progression to diabetic ketoacidosis (DKA), which is a life-threatening condition. 1, 2

Initial Assessment

  • Evaluate for symptoms of hyperglycemia such as thirst, frequent urination, blurry vision, and assess for more severe symptoms including nausea, vomiting, abdominal pain, and altered mental status 1, 2
  • Check for ketones in blood or urine to assess for diabetic ketoacidosis 2, 3
  • Assess vital signs, hydration status, and level of consciousness 3
  • Evaluate for precipitating factors such as infection, medication non-adherence, or new-onset diabetes 2, 3

Immediate Management

Fluid Resuscitation

  • Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr to restore circulatory volume and tissue perfusion 2, 3
  • After the first hour, continue fluid replacement based on hemodynamic status, typically at 4-14 mL/kg/hr 2
  • Adequate fluid intake is crucial as dehydration increases the risk of complications and hospitalization 2, 4

Insulin Therapy

  • For critically ill patients or those with severe hyperglycemia (>500 mg/dL), intravenous insulin infusion is the preferred method 1
  • Start continuous intravenous regular insulin at 0.1 units/kg/hr after fluid resuscitation has begun 2, 3
  • If glucose does not fall by 50-75 mg/dL in the first hour, double the insulin infusion rate 2, 3
  • Once blood glucose reaches 200-250 mg/dL, add dextrose to IV fluids while continuing insulin infusion to prevent hypoglycemia 2, 3

Electrolyte Management

  • Monitor serum potassium levels every 2-4 hours as insulin therapy can cause hypokalemia 2, 3
  • Begin potassium replacement when serum levels fall below 5.2 mEq/L, provided the patient has adequate urine output 2, 3
  • Typical potassium replacement is 20-30 mEq per liter of IV fluid 2, 3

Ongoing Monitoring

  • Check blood glucose every 1-2 hours until stable 2, 3
  • Monitor electrolytes, blood urea nitrogen, creatinine, and venous pH every 2-4 hours 2, 3
  • Assess for signs of cerebral edema, particularly in children and adolescents 2, 3
  • Watch for symptoms of hypoglycemia during treatment including sweating, drowsiness, dizziness, anxiety, tremor, and hunger 5

For Non-Critical Hyperglycemia (Outpatient Setting)

If the patient is alert, not in distress, and without signs of DKA:

  • Administer subcutaneous rapid-acting insulin at an appropriate dose (typically 0.1-0.2 units/kg) 1
  • Ensure adequate hydration with sugar-free fluids 1
  • Monitor blood glucose levels every 1-2 hours 1
  • Seek medical attention if symptoms worsen or blood glucose remains elevated 1, 5

Prevention of Future Episodes

  • Review sick-day management with patients, including when to contact healthcare providers 2, 3
  • Advise patients never to discontinue insulin during illness and to seek professional advice early 2, 3
  • Educate patients on monitoring blood glucose and urine ketones when blood glucose is >300 mg/dL 2, 3

Complications to Watch For

  • Diabetic ketoacidosis: characterized by nausea, vomiting, abdominal pain, and high ketone levels 1, 5
  • Hyperosmolar hyperglycemic state: extreme hyperglycemia without significant ketosis, often with altered mental status 4
  • Cerebral edema: more common in children, presenting with headache, altered mental status, seizures 2, 3
  • Hypokalemia during insulin treatment: can lead to cardiac arrhythmias 5

Pitfalls to Avoid

  • Using only sliding scale insulin (SSI) as the sole method of treatment is strongly discouraged as it is reactive rather than preventative 1
  • Failing to identify and treat the underlying cause of hyperglycemia 2, 3
  • Neglecting to monitor for hypoglycemia when insulin therapy is initiated 5
  • Discontinuing insulin therapy too early before the hyperglycemic crisis is fully resolved 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperglycemic crisis.

The Journal of emergency medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.